Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Orange Capital Cuts Bellatrix Exploration Ltd. (BXE) Position, Daniel Lewis Resigns from Board

Page 1 of 9
Bellatrix Exploration Ltd (NYSE:BXE) is the subject of a new 13D filing issued by Daniel LewisOrange Capital, which reveals the most up-to-date ownership information of the investment firm in the stock. Orange Capital holds 30.83 million shares of the Canadian energy company, which represents a 1.90 million-share reduction from the firm’s position reported as of November 30. The activist filing also reveals that Mr. Lewis has resigned from Bellatrix’s Board of Directors, effective February 10. You can peruse the filing below and on the following pages.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Orange Capital, 0 30,827,712 0 30,827,712 30,827,712 16.1%
Orange Capital Master I, Ltd. 0 19,997,380 0 19,997,380 19,997,380 10.4%
OC Offshore Investments II, SPC Segregated Portfolio A 0 4,022,277 0 4,022,277 4,022,277 2.1%
OC Offshore Investments II, SPC Segregated Portfolio B 0 6,808,055 0 6,808,055 6,808,055 3.5%
Daniel Lewis 0 30,827,712 0 30,827,712 30,827,712 16.1%
Daniel Lewis
Daniel Lewis
Orange Capital

Page 1 of 9 SEC Filing

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 12)*

Bellatrix
Exploration Ltd.

(Name of Issuer)

Common Shares,
no par value

(Title of Class of Securities)

078314101

(CUSIP Number)
Eleazer Klein, Esq.
Schulte Roth & Zabel LLP
919 Third Avenue

New York,
New York 10022

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

February
10, 2016

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule
13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule
13d-1(f) or Rule 13d-1(g), check the following box. [ ]

(Page 1 of 9 Pages)

______________________________

* The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or
otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).

Page 1 of 9

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!